Groowe Groowe / Newsroom / TPST
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TPST News

Tempest Therapeutics, Inc. Common Stock

Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026

globenewswire.com
TPST

Form 8-K

sec.gov
TPST

Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026

globenewswire.com
TPST

Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets

globenewswire.com
TPST

Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets

globenewswire.com
TPST

Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders

globenewswire.com
TPST

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

globenewswire.com
TPST

Tempest Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

globenewswire.com
TPST

Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027

globenewswire.com
TPST BTX

Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update

globenewswire.com
TPST